Due to the autocrine/paracrine of PRL, although the pooled data suggest that PRL-increasing and PRL-sparing antipsychotics pose a similar risk of breast cancer, we cannot deny the role of PRL in breast cancer. Here, PRL is linked to breast carcinoma.